Tektite Genome

Long Beach, United States

Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.

$2.4M raised

Dec 2025

Series A

Artificial Intelligence (AI)Biotechnology Genetics Predictive Analytics Robotics

Top Investors

Steven Crow

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tektite Genome

How much funding has Tektite Genome raised?

Tektite Genome has raised $2.4M in total funding. The most recent round was Series A. The last funding was announced in December 2025.

Who are Tektite Genome's investors?

Tektite Genome's investors include Steven Crow.

Where is Tektite Genome headquartered?

Tektite Genome is headquartered in Long Beach, United States.

What does Tektite Genome do?

Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.

What stage is Tektite Genome at?

Tektite Genome is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 10, 2025.

MLA

"Tektite Genome — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/tektite-genome. Accessed July 2, 2026.

APA

VCBacked. (2025). Tektite Genome — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tektite-genome

Wikipedia (cite web)

{{cite web |title=Tektite Genome — Funding & Investors |url=https://www.vcbacked.co/company/tektite-genome |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 10, 2025.

Similar Companies in Artificial Intelligence (AI)

Fort Lauderdale$50.0M